Glenmark Generics receives final ANDA approvals for Zolmitriptan tablets

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approvals (ANDA’s) from the USFDA for Zolmitriptan Tablets, 2.5 and 5mg and Zolmitriptan Orally Disintegrating Tablets, 2.5 and 5mg. Glenmark will commence distribution of the product immediately.

May 15, 2013 / 12:21 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated May 15, 2013 titled "Glenmark Generics receives final ANDA approvals for Zolmitriptan Tablest, 2.5 and 5 mg and Zolmitriptan Orally Disintegrating Tablest, 2.5 and 5 mg."Source : BSE

Read all announcements in Glenmark

first published: May 15, 2013 12:21 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347